MedPath

University of Vermont

University of Vermont logo
🇺🇸United States
Ownership
Private
Established
1791-01-01
Employees
51
Market Cap
-
Website
http://www.uvm.edu

Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

Not Applicable
Recruiting
Conditions
Chemotherapy-induced Peripheral Neuropathy
Interventions
Other: Symptom Care at Home with NP follow up
First Posted Date
2021-02-21
Last Posted Date
2025-03-03
Lead Sponsor
University of Vermont
Target Recruit Count
422
Registration Number
NCT04763356
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

🇺🇸

University of Vermont, Burlington, Vermont, United States

🇺🇸

Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States

Personalized Pacing: A New Paradigm for Patients With Diastolic Dysfunction or Heart Failure With Preserved Ejection Fraction

Not Applicable
Completed
Conditions
Pacemaker
Diastolic Dysfunction
Diastolic Heart Failure
Interventions
Device: Maintenance of lower rate limit
Device: Adjustment of lower rate limit
First Posted Date
2021-01-22
Last Posted Date
2022-02-09
Lead Sponsor
University of Vermont
Target Recruit Count
123
Registration Number
NCT04721314
Locations
🇺🇸

University of Vermont Medical Center, Burlington, Vermont, United States

E-cigarette Nicotine Study

Phase 2
Completed
Conditions
Nicotine Dependence
Electronic Cigarette Use
Cigarette Smoking
Interventions
Device: Juul e-cigarette
Behavioral: Reduction
First Posted Date
2021-01-14
Last Posted Date
2022-08-26
Lead Sponsor
University of Vermont
Target Recruit Count
77
Registration Number
NCT04709471
Locations
🇺🇸

University of Vermont, Burlington, Vermont, United States

Do Flavors Increase the Addiction Potential of Nicotine?

Phase 2
Completed
Conditions
Nicotine Dependence
Interventions
Device: JUUL e-cigarette
First Posted Date
2021-01-06
Last Posted Date
2022-03-22
Lead Sponsor
University of Vermont
Target Recruit Count
19
Registration Number
NCT04696380
Locations
🇺🇸

University of Vermont, Burlington, Vermont, United States

Exploring the Optimal Duration of a Group-based Online Behavioral Weight Loss Program

Not Applicable
Withdrawn
Conditions
Obesity and Overweight
Interventions
Behavioral: Four Month Duration Online Behavioral Weight Loss Program
Behavioral: Six Month Duration Online Behavioral Weight Loss Program
First Posted Date
2020-11-13
Last Posted Date
2020-11-13
Lead Sponsor
University of Vermont
Registration Number
NCT04628533
Locations
🇺🇸

University of South Carolina, Columbia, South Carolina, United States

🇺🇸

Behavioral Weight Management Program/Univ of Vermont, Burlington, Vermont, United States

Start Treatment and Recovery for Opioid Use Disorder

Not Applicable
Completed
Conditions
Opioid-use Disorder
Opioid Medication Assisted Treatment
Mental Disorder
Interventions
Other: Bridge Clinic
First Posted Date
2020-08-10
Last Posted Date
2023-12-11
Lead Sponsor
University of Vermont
Target Recruit Count
104
Registration Number
NCT04505540
Locations
🇺🇸

University of Vermont Medical Center, Burlington, Vermont, United States

PACE Vape Messaging Study

Not Applicable
Completed
Conditions
Vaping
E-cigarette Use
Electronic Cigarette Use
Interventions
Behavioral: Vape Messaging Intervention
First Posted Date
2020-06-29
Last Posted Date
2020-11-03
Lead Sponsor
University of Vermont
Target Recruit Count
569
Registration Number
NCT04450537
Locations
🇺🇸

University of Vermont, Burlington, Vermont, United States

COVID Cohort Study

Terminated
Conditions
COVID-19
Acute Respiratory Failure
Interventions
Other: COVID-19+ observational
First Posted Date
2020-05-19
Last Posted Date
2021-02-12
Lead Sponsor
University of Vermont
Target Recruit Count
16
Registration Number
NCT04393155
Locations
🇺🇸

University of Vermont College of Medicine, Burlington, Vermont, United States

Improving Smoking Cessation in Socioeconomically-Disadvantaged Young Adults

Not Applicable
Completed
Conditions
Nicotine Dependence, Cigarettes
Interventions
Behavioral: Web + text smoking cessation intervention
First Posted Date
2020-05-07
Last Posted Date
2021-02-11
Lead Sponsor
University of Vermont
Target Recruit Count
437
Registration Number
NCT04379388
Locations
🇺🇸

University of Vermont, Burlington, Vermont, United States

Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer

Phase 1
Conditions
Lung Cancer Metastatic
First Posted Date
2020-03-17
Last Posted Date
2022-05-23
Lead Sponsor
University of Vermont
Target Recruit Count
9
Registration Number
NCT04311762
Locations
🇺🇸

University of Vermont, Burlington, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath